Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactamica 7: N. lactamica Challenge
NCT03633474Phase 1Completed
- Sponsor
- University of Southampton
- Start
- Sep 2018
- Primary completion
- Sep 2019
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of Neisseria lactamica in bacterial meningitis (2 arms), sponsored by University of Southampton. Primary endpoint: Host T-cell and B-cell memory responses and plasma B-cell responses in blood at Day 33. Started Sep 2018; status: completed.
02
Drugs
Neisseria lactamica
03
Conditions
bacterial meningitis
Beyond the preview
Go deeper on NCT03633474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03633474.